BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xin S, Deng Y, Mao J, Wang T, Liu J, Wang S, Song X, Song W, Liu X. Characterization of 7-Methylguanosine Identified Biochemical Recurrence and Tumor Immune Microenvironment in Prostate Cancer. Front Oncol 2022;12:900203. [PMID: 35677157 DOI: 10.3389/fonc.2022.900203] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Li DX, Feng DC, Wang XM, Wu RC, Zhu WZ, Chen K, Han P. M7G-related molecular subtypes can predict the prognosis and correlate with immunotherapy and chemotherapy responses in bladder cancer patients. Eur J Med Res 2023;28:55. [PMID: 36732869 DOI: 10.1186/s40001-023-01012-x] [Reference Citation Analysis]
2 Ye X, Wang R, Yu X, Wang Z, Hu H, Zhang H. m6A/ m1A /m5C/m7G-related methylation modification patterns and immune characterization in prostate cancer. Front Pharmacol 2022;13:1030766. [DOI: 10.3389/fphar.2022.1030766] [Reference Citation Analysis]